Expression of gp100, MART-1, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: implications for diagnosis and immunotherapy. A study conducted by the EORTC Melanoma Cooperative Group
T. J. de Vries(Radboud University Nijmegen), Dirk J. Ruiter(Radboud University Nijmegen), Nathalie Renard(Institut Jules Bordet), Miriam Smeets(Radboud University Nijmegen), Ruurd de Graaf(Radboud University Nijmegen), Eva B. Bröcker(Klinik und Poliklinik für Hautkrankheiten), K Hou-Jensen, Goos N.P. van Muijen(Radboud University Medical Center), Alexander M.M. Eggermont(University Medical Center Utrecht)
Cited by 108
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Final Version of 2009 AJCC Melanoma Staging and Classification
|Journal of Clinical Oncology|2009|4.6k
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
|CA A Cancer Journal for Clinicians|2017|2.3k
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
|New England Journal of Medicine|2018|1.9k